Apellis Pharmaceuticals Inc (APLS)
28.06
-0.19
(-0.67%)
USD |
NASDAQ |
Nov 14, 16:00
28.04
-0.02
(-0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Gross Profit (Annual): 338.08M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 338.08M |
| December 31, 2022 | 69.79M |
| December 31, 2021 | 61.36M |
| Date | Value |
|---|---|
| December 31, 2020 | 225.60M |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
2019
338.08M
Maximum
2023
138.97M
Average
69.79M
Median
2022
Gross Profit (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 1.904B |
| Ionis Pharmaceuticals Inc | 778.51M |
| EyePoint Pharmaceuticals Inc | 41.39M |
| Cassava Sciences Inc | -- |
| Macrogenics Inc | 48.97M |